R. Sousa1, P. Lage1, I. Claro1, M. Ferreira2, J. Raposo4, J. Cabeçadas3, A. Dias Pereira1, C. Nobre-Leitão1
Texto Completo disponível apenas em PDF
Full text only available in PDF format
Bibliografia
1. Classen J, Belka C, Paulsen F, Budach W, Hoffmann W, Bamberg M, et al. Radiation-induced gastrointestinal toxicity. Pathophysiology, approaches to treatment and prophylaxis. Strahlenther Onkol 1998; 174: 82-4. [ Links ]
2. Yeung RS, Weese JL, Hoffman JP, Solin LJ, Paul AK, Engstrom PF, et al. Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A phase II study. Cancer 1993; 72: 2124-33.
]]> 3. Shepherd FA, Rotstein LE, Houle S. A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocelular carcinoma. Cancer 1992; 70: 2250-4.4. Talamonti MS, Catalano PJ, Vaughn DJ, Whittingtom R, Beauchamp RD, Berlin J, et al. Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity. J Clin Oncol 2000; 18: 3384-9.
(1) Serviço de Gastrenterologia.
(2) Serviço de Oncologia Médica.
(3) Serviço de Anatomia Patológica.
(4) Serviço de Radioterapia.
Instituto Português de Oncologia de Francisco Gentil - CROL, SA.
]]>Recebido para publicação: 21/03/2005
Aceite para publicação: 04/01/2006
]]>